Ajooni Biotech Q1 FY27: revenue doubles, profit halves

Revenue Growth 20pctEbitda Margin CompressionResults View source PDF Explain this filing

AJOONI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.1%Reaction day

₹3.89

prior close

₹3.86

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-2.2% vs market

Animal Feed peers, median of 6sector+0.8%-2.9% vs sector

On the reaction day the stock moved 2.2 pts less than Nifty Microcap 250 and 2.9 pts less than its Animal Feed peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.3

10m

+0.3

15m

+0.0

30m

-1.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.1+0.1-2.2+0.8-2.9

Next day

-2.3+0.5-2.8+0.9-3.2

-2.6-0.1-2.5-1.1-1.5

-3.6+0.4-4.0-0.3-3.3

-3.9+0.7-4.5-1.4-2.4

-3.9+0.9-4.8-3.6-0.3

+0.3+1.1-0.8-3.0+3.2

15d

-10.0+1.6-11.6+4.4-14.5

-15.7-0.7-14.9-1.1-14.6

-24.7-3.2-21.4-7.4-17.2

—————

UpDownMarket · Nifty Microcap 250Sector · Animal Feed peers, median of 6Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Revenue from operations doubled to about Rupees 6,349 lakhs in Q1 FY27 from about Rupees 3,127 lakhs a year ago. Net profit fell sharply to about Rupees 43 lakhs from about Rupees 78 lakhs, with EPS at about Rupees 0.01 versus 0.02. Finance costs jumped from about 8 to 48 lakhs and depreciation rose from about 25 to 80 lakhs, squeezing margins. Auditor issued a clean limited review report.

Likely market impact

Strong top-line growth but sharp profit dip from higher finance and depreciation costs. Margins under pressure despite revenue doubling.